FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001143248> ?p ?o ?g. }

• W2001143248 endingPage "735" @default.
• W2001143248 startingPage "729" @default.
• W2001143248 abstract "Background Recent studies have revealed that Glasgow prognostic score (GPS), an inflammation-based prognostic score, is associated with poor outcome in a variety of tumors. However, few studies have investigated whether GPS measured prior to neoadjuvant chemoradiotherapy (nCRT) is useful for postoperative prognosis of patients with advanced esophageal squamous cell carcinoma (ESCC). Methods GPS was calculated on the basis of admission data as follows: patients with both an elevated C-reactive protein (>10 mg/L) and hypoalbuminaemia (<35 g/L) were allocated a GPS score of 2. Patients in whom only 1 of these biochemical abnormalities was present were allocated a GPS score of 1, and patients with a normal C-reactive protein and albumin were allocated a score of 0. All patients underwent radical en-bloc resection 3–4 weeks after nCRT. Results A total of 48 patients with clinical TNM stage II/III were enrolled. Univariate analyses revealed that there were significant differences in cancer-specific survival in relation to grade of response to nCRT (P = .004), lymph node status (P = .0065), lymphatic invasion (P = .0002), venous invasion (P = .0001), pathological TNM classification (P = .015), and GPS (P < .0001). GPS classification showed a close relationship with lymphatic invasion, venous invasion, and number of lymph node (P = .0292, .0473, and .0485, respectively). GPS was found to be the only independent predictor of cancer-specific survival (odds ratio, 0.17; 95% confidence interval, 0.06–0.52; P = .0019). Conclusions GPS, measured prior to nCRT, is an independent novel predictor of postoperative outcome in patients with advanced ESCC. Recent studies have revealed that Glasgow prognostic score (GPS), an inflammation-based prognostic score, is associated with poor outcome in a variety of tumors. However, few studies have investigated whether GPS measured prior to neoadjuvant chemoradiotherapy (nCRT) is useful for postoperative prognosis of patients with advanced esophageal squamous cell carcinoma (ESCC). GPS was calculated on the basis of admission data as follows: patients with both an elevated C-reactive protein (>10 mg/L) and hypoalbuminaemia (<35 g/L) were allocated a GPS score of 2. Patients in whom only 1 of these biochemical abnormalities was present were allocated a GPS score of 1, and patients with a normal C-reactive protein and albumin were allocated a score of 0. All patients underwent radical en-bloc resection 3–4 weeks after nCRT. A total of 48 patients with clinical TNM stage II/III were enrolled. Univariate analyses revealed that there were significant differences in cancer-specific survival in relation to grade of response to nCRT (P = .004), lymph node status (P = .0065), lymphatic invasion (P = .0002), venous invasion (P = .0001), pathological TNM classification (P = .015), and GPS (P < .0001). GPS classification showed a close relationship with lymphatic invasion, venous invasion, and number of lymph node (P = .0292, .0473, and .0485, respectively). GPS was found to be the only independent predictor of cancer-specific survival (odds ratio, 0.17; 95% confidence interval, 0.06–0.52; P = .0019). GPS, measured prior to nCRT, is an independent novel predictor of postoperative outcome in patients with advanced ESCC." @default.
• W2001143248 created "2016-06-24" @default.
• W2001143248 creator A5001942473 @default.
• W2001143248 creator A5002653535 @default.
• W2001143248 creator A5017257757 @default.
• W2001143248 creator A5052586730 @default.
• W2001143248 creator A5054965573 @default.
• W2001143248 creator A5073046727 @default.
• W2001143248 creator A5076156089 @default.
• W2001143248 creator A5080355716 @default.
• W2001143248 creator A5081750005 @default.
• W2001143248 date "2008-11-01" @default.
• W2001143248 modified "2023-10-18" @default.
• W2001143248 title "Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma" @default.
• W2001143248 cites W1938627666 @default.
• W2001143248 cites W1964589228 @default.
• W2001143248 cites W1965037168 @default.
• W2001143248 cites W1985354647 @default.
• W2001143248 cites W1988533647 @default.
• W2001143248 cites W1993133962 @default.
• W2001143248 cites W1996552994 @default.
• W2001143248 cites W2003861472 @default.
• W2001143248 cites W2011532948 @default.
• W2001143248 cites W2017143663 @default.
• W2001143248 cites W2023851164 @default.
• W2001143248 cites W2029081428 @default.
• W2001143248 cites W2034681353 @default.
• W2001143248 cites W2046279698 @default.
• W2001143248 cites W2050736077 @default.
• W2001143248 cites W2053545935 @default.
• W2001143248 cites W2065216271 @default.
• W2001143248 cites W2078878717 @default.
• W2001143248 cites W2085186223 @default.
• W2001143248 cites W2089001382 @default.
• W2001143248 cites W2091269486 @default.
• W2001143248 cites W2094703627 @default.
• W2001143248 cites W2116554142 @default.
• W2001143248 cites W2116964952 @default.
• W2001143248 cites W2120603938 @default.
• W2001143248 cites W2169906597 @default.
• W2001143248 cites W2313229551 @default.
• W2001143248 cites W2333224485 @default.
• W2001143248 cites W4229906917 @default.
• W2001143248 doi "https://doi.org/10.1016/j.surg.2008.08.015" @default.
• W2001143248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19081014" @default.
• W2001143248 hasPublicationYear "2008" @default.
• W2001143248 type Work @default.
• W2001143248 sameAs 2001143248 @default.
• W2001143248 citedByCount "84" @default.
• W2001143248 countsByYear W20011432482012 @default.
• W2001143248 countsByYear W20011432482013 @default.
• W2001143248 countsByYear W20011432482014 @default.
• W2001143248 countsByYear W20011432482015 @default.
• W2001143248 countsByYear W20011432482016 @default.
• W2001143248 countsByYear W20011432482017 @default.
• W2001143248 countsByYear W20011432482018 @default.
• W2001143248 countsByYear W20011432482019 @default.
• W2001143248 countsByYear W20011432482020 @default.
• W2001143248 countsByYear W20011432482021 @default.
• W2001143248 countsByYear W20011432482023 @default.
• W2001143248 crossrefType "journal-article" @default.
• W2001143248 hasAuthorship W2001143248A5001942473 @default.
• W2001143248 hasAuthorship W2001143248A5002653535 @default.
• W2001143248 hasAuthorship W2001143248A5017257757 @default.
• W2001143248 hasAuthorship W2001143248A5052586730 @default.
• W2001143248 hasAuthorship W2001143248A5054965573 @default.
• W2001143248 hasAuthorship W2001143248A5073046727 @default.
• W2001143248 hasAuthorship W2001143248A5076156089 @default.
• W2001143248 hasAuthorship W2001143248A5080355716 @default.
• W2001143248 hasAuthorship W2001143248A5081750005 @default.
• W2001143248 hasConcept C121608353 @default.
• W2001143248 hasConcept C126322002 @default.
• W2001143248 hasConcept C143998085 @default.
• W2001143248 hasConcept C144301174 @default.
• W2001143248 hasConcept C146357865 @default.
• W2001143248 hasConcept C151730666 @default.
• W2001143248 hasConcept C156957248 @default.
• W2001143248 hasConcept C207886595 @default.
• W2001143248 hasConcept C2777297899 @default.
• W2001143248 hasConcept C2777546739 @default.
• W2001143248 hasConcept C2778292576 @default.
• W2001143248 hasConcept C2778424827 @default.
• W2001143248 hasConcept C2778740770 @default.
• W2001143248 hasConcept C2779013556 @default.
• W2001143248 hasConcept C2779742542 @default.
• W2001143248 hasConcept C2780849966 @default.
• W2001143248 hasConcept C38180746 @default.
• W2001143248 hasConcept C44249647 @default.
• W2001143248 hasConcept C530470458 @default.
• W2001143248 hasConcept C71924100 @default.
• W2001143248 hasConcept C86803240 @default.
• W2001143248 hasConcept C90924648 @default.
• W2001143248 hasConceptScore W2001143248C121608353 @default.
• W2001143248 hasConceptScore W2001143248C126322002 @default.
• W2001143248 hasConceptScore W2001143248C143998085 @default.
• W2001143248 hasConceptScore W2001143248C144301174 @default.
• W2001143248 hasConceptScore W2001143248C146357865 @default.
• W2001143248 hasConceptScore W2001143248C151730666 @default.

• next